Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.96 USD | -3.36% | -6.80% | -8.57% |
04-01 | Quince Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
03-26 | Transcript : Quince Therapeutics, Inc. - Special Call |
Chart calendar Quince Therapeutics, Inc.
Upcoming events on Quince Therapeutics, Inc.
Past events on Quince Therapeutics, Inc.
2024-04-01 07:00 | Q4 2023 Earnings Release |
2024-02-14 10:40 | Oppenheimer Healthcare Life Sciences Conference |
2024-01-09 18:30 | Biotech Showcase |
2024-01-07 14:00 | Neuroscience Innovation Forum |
2023-08-17 15:15 | Sidoti Virtual Investor Conference |
2023-07-24 07:00 | Acquisition of EryDel SpA By Quince Therapeutics Inc Call |
2023-05-24 14:00 | Annual General Meeting |
2022-09-11 | Military Health System Research Symposium |
2022-09-08 | American Society for Bone and Mineral Research Meeting |
2022-08-29 | Osteogenesis Imperfecta International Conference |
2022-08-11 09:00 | Canaccord Growth Conference |
2022-08-08 | Interim 2022 Earnings Release |
2022-06-08 14:00 | Annual General Meeting |
2022-05-14 | Porphyromonas gingivalis and Related Species in Oral and Systemic Diseases International Conference |
2022-03-20 05:50 | Alzheimer and Parkinson Diseases and Related Neurological Disorders International Conference |
2021-11-30 13:25 | Evercore ISI HealthCONx Conference |
2021-11-11 11:35 | Clinical Trials on Alzheimer's Disease Conference |
2021-11-08 | Clinical Trials on Alzheimer's Disease Conference |
2021-10-26 16:30 | Business Update Call |
2021-09-13 07:00 | H.C. Wainwright Global Investment Conference |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 |
---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - |
EBITDA Million USD | Released Forecast Spread | -39,0 -37,9 -2.89% | -78,6 -80,5 2.36% | -90,0 -89,7 -0.28% |
EBIT Million USD | Released Forecast Spread | -39,2 -37,7 -3.85% | -78,9 -81,1 2.68% | -90,3 -89,5 -0.87% |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -37,0 -35,8 -3.32% | -76,8 -79,0 2.78% | -89,9 -89,9 -0.03% |
Net income Million USD | Released Forecast Spread | -37,0 -35,8 -3.39% | -76,8 -78,9 2.55% | -89,9 -89,2 -0.79% |
EPS USD | Released Forecast Spread | -1,94 -2,03 4.21% | -2,63 -2,59 -1.43% | -3,03 -2,80 -8.37% |
Announcement Date | 16/03/20 | 01/03/21 | 01/03/22 |
Quarterly results
Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 |
---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - |
EBITDA Million USD | Released Forecast Spread | -23,5 -22,9 -2.45% | -21,8 -11,9 -83.4% | -16,2 -12,9 -25.38% |
EBIT Million USD | Released Forecast Spread | -23,5 -23,6 0.42% | -21,9 -16,8 -29.89% | -16,3 -18,3 11.01% |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -23,4 -21,3 -9.84% | -21,6 -17,6 -22.68% | -16,8 -18,1 7.12% |
Net income Million USD | Released Forecast Spread | -23,4 -21,7 -7.89% | -21,6 -16,7 -29.63% | -16,6 -18,1 8.69% |
EPS USD | Released Forecast Spread | -0,78 -0,65 -19.63% | -0,72 -0,60 -19.34% | -0,51 -0,61 15.93% |
Announcement Date | 01/03/22 | 10/05/22 | 09/08/22 |
Past sector events for Quince Therapeutics, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- QNCX Stock
- Calendar Quince Therapeutics, Inc.